Clorox (NYSE:CLX) Price Target Raised to $173.00

Clorox (NYSE:CLX) had its target price boosted by investment analysts at JPMorgan Chase & Co. from $171.00 to $173.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 14.09% from the stock’s current price.

CLX has been the topic of a number of other reports. DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Wells Fargo & Company lifted their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Finally, Barclays lowered their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a report on Friday, January 17th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $156.50.

Clorox Stock Performance

Shares of CLX stock traded down $8.14 during trading hours on Tuesday, reaching $151.64. 1,260,216 shares of the company’s stock were exchanged, compared to its average volume of 1,128,591. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a market cap of $18.77 billion, a P/E ratio of 52.74, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company’s 50 day moving average is $162.76 and its two-hundred day moving average is $158.50.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period last year, the firm earned $2.16 EPS. Equities research analysts anticipate that Clorox will post 6.86 EPS for the current fiscal year.

Institutional Trading of Clorox

A number of institutional investors and hedge funds have recently modified their holdings of CLX. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC bought a new stake in Clorox in the 3rd quarter valued at $27,000. Continuum Advisory LLC raised its stake in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares in the last quarter. Asset Planning Inc acquired a new stake in shares of Clorox during the 4th quarter valued at about $32,000. Finally, Carolina Wealth Advisors LLC bought a new stake in Clorox in the third quarter valued at about $48,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.